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ABSTRACT
The initiation and regulation of transcription in eu-
karyotes is complex and involves a large number of
transcription factors (TFs), which are known to bind
to the regulatory regions of eukaryotic DNA. Apart
from TF–DNA binding, protein–protein interaction
involving TFs is an essential component of the
machinery facilitating transcriptional regulation.
Proteins that interact with TFs in the context of tran-
scription regulation but do not bind to the DNA
themselves, we consider transcription co-factors
(TcoFs). The influence of TcoFs on transcriptional
regulation and initiation, although indirect, has
been shown to be significant with the functionality
of TFs strongly influenced by the presence of TcoFs.
While the role of TFs and their interaction with regu-
latory DNA regions has been well-studied, the asso-
ciation between TFs and TcoFs has so far been
given less attention. Here, we present a resource
that is comprised of a collection of human TFs and
the TcoFs with which they interact. Other proteins
that have a proven interaction with a TF, but are not
considered TcoFs are also included. Our database
contains 157 high-confidence TcoFs and addition-
ally 379 hypothetical TcoFs. These have been
identified and classified according to the type of
available evidence for their involvement in transcrip-
tional regulation and their presence in the cell
nucleus. We have divided TcoFs into four groups,
one of which contains high-confidence TcoFs and
three others contain TcoFs which are hypothetical
to different extents. We have developed the Dragon
Database for Human Transcription Co-Factors and
Transcription Factor Interacting Proteins (TcoF-DB).
A web-based interface for this resource can be
freely accessed at http://cbrc.kaust.edu.sa/tcof/
and http://apps.sanbi.ac.za/tcof/.
INTRODUCTION
It is known that initiation and regulation of transcription
in eukaryotic cells is a complex process. It is widely
accepted that it constitutes a vastly complex process
involving a large number of proteins interacting with the
regulatory regions of DNA in various ways (1–5).
Additionally, the process involves numerous proteins
that do not themselves interact with the DNA molecule,
but instead interact with DNA binding proteins, forming
complexes that could themselves interact with DNA (6,7).
This phenomenon signiﬁcantly increases the complexity of
the process of transcriptional regulation and initiation.
Proteins that bind DNA and in this way affect the regu-
lation of transcription are in this context referred to as
transcription factors (TFs) (8). At the same time
proteins that are not DNA binding in the context of tran-
scriptional regulation, but are nevertheless involved in this
process through the interaction with TFs are referred to as
transcription co-factors (TcoFs) (9,10). The functions that
TcoFs are known to have are multiple and include, among
others, signal transmission, modulation of TF–DNA
binding and chromatin modiﬁcation (11,12).
Apart from the interaction of TFs with the regulatory
regions of the DNA molecule, the interactions between
proteins (protein–protein interaction, PPI) are of import-
ance for understanding the mechanisms of transcriptional
regulation. PPIs include various forms of relationships
between two proteins, e.g. the modiﬁcation of one
protein by another protein, the transport of one protein
from one cellular location to another by another protein
or the formation of a protein complex by two or more
proteins, etc. PPIs of our interest that are important for
the processes of transcriptional regulation include the
physical interaction between two TFs, the physical
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the physical interaction between a TF and another protein
that cannot be regarded as a TcoF.
The speciﬁc inﬂuence of TFs on transcription is widely
accepted to be an important component in gene expression
(13). It has been recognized that TFs can have an inﬂuence
on disease development (14) and they have been previous-
ly identiﬁed as potential targets in cancer therapy (15–18)
or cancer diagnostic biomarkers (19). The functionality of
TFs has also been shown to be important for the devel-
opment of treatments for a number of other human
diseases (20–23). However, research on the interaction of
TFs with other proteins in relation to transcription regu-
lation has so far not been that intensive. It has previously
been shown that PPI can be linked to organism complexity
(24). It has also been shown that the same TF can have
opposite functions depending on its interactions with
TcoFs (25). We therefore believe that in order to get a
more complete insight into the complexity of transcrip-
tional regulatory processes and more accurately describe
the role of TFs and TcoFs in relation to human diseases it
is imperative to investigate TFs in conjunction with their
interacting proteins.
With this in mind, we developed a public resource:
Dragon Database for Human Transcription Co-Factors
and Transcription Factor Interacting Proteins (TcoF-
DB). With this database, we wish to provide a compre-
hensive starting point for investigations into transcription-
al regulation that include PPIs between TFs, TFs and
TcoFs, as well as between TFs and other proteins. While
there are numerous resources available that deal with
either the complete human proteome (26–29), human
PPI (30–33) or mammalian TFs (34–36), we are not
aware of a resource that uniﬁes the data necessary to
directly investigate human TFs, human TcoFs and other
human proteins that interact with TFs. TcoF-DB attempts
to reduce this gap.
DATA INTEGRATION AND ANALYSIS
We generated a highly accurate set of human TFs. For
this, we rely on data that was previously published by
Vaquerizas et al. (13) and that we regard to be a
gold-standard due to the meticulous way in which it was
created. We extracted all TFs from that reference. This set
constitutes all human proteins that possess a sequence
speciﬁc DNA binding domain and additionally have
passed a step of manual curation during which each
protein was examined by a human curator for being a
TF with high conﬁdence. In addition to this, we extracted
70 proteins that are included in TRANSFAC 11.4 (34) but
were not included in the list published by Vaquerizas et al.
We manually checked each of these proteins and added 19
of them to our list of human TFs. To complement our set
of TFs further, we ﬁnally extracted mouse TF genes from
TFCAT (37) whose protein products bind DNA in a
sequence speciﬁc as well as a non-sequence speciﬁc
manner. For these mouse genes, we identiﬁed human
ortholog genes using NCBI’s Homologene (38) and their
gene products, if available. We manually checked each of
these proteins that were not already included in our set
and added eight proteins from TFCAT to our TF list. In
total, we identiﬁed 1365 human TFs in this way. It should
be highlighted that each TF in this list has been hand
curated at some point during the process.
Four public databases of human PPIs were used to
extract PPIs. These were MINT (accessed July 2010)
(39), IntAct (accessed July 2010) (31), BioGRID version
3.0.67 (30) and Reactome version 33 (40). These databases
were selected because they allow for the download of data
in the format suitable for processing by a computer. All
data in these four databases is experimentally conﬁrmed.
It was of particular importance that this information is
presented in the PSI-MI format [molecular interaction
standard of the Proteomics Standards Initiative (41)] in
order to allow us to focus on PPI of a certain type. We
only consider PPIs that represent physical interactions
between two proteins. Thus, considered PSI-MI inter-
action types were one of the following:
. MI:0195 (covalent binding),
. MI:0407 (direct interaction),
. MI:0915 (physical association).
In this manner, we were able to extract 7045 unique inter-
actions between two proteins where at least one of the
participants is a TF from our list and the interaction is
one of the above mentioned physical interactions.
All proteins that were identiﬁed as having a physical
interaction with a known TF and are not themselves
included in our reference list of TFs are initially con-
sidered ‘TF interacting proteins’. Evidence for the inter-
action is extracted from one of the aforementioned
databases and added to our database. In total, 2300
distinct human proteins have been found to interact with
one of 712 TF. This leaves 653 TFs from our list for which
we were not able to ﬁnd a known interaction with another
protein.
Out of these 2300 proteins, we subsequently endeav-
oured to identify those proteins that can be considered
TcoFs. First, we postulated the necessary condition that
a TcoF candidate is known to be located in the cell
nucleus. For this, we check whether the protein in
question is annotated in Gene Ontology (GO) (42) with
term GO:0005634 (cellular component: ‘nucleus’). For this
we use AmiGO version 1.7 (43). We do not consider
proteins that do not possess this annotation as TcoFs.
Second, we require that a TcoF candidate is known to
be involved in transcriptional regulation. For this condi-
tion, we check whether the protein in questions is
annotated in GO with either GO:0030528 (molecular
function: ‘transcription regulator activity’) or one of its
descendent terms, or with GO:0045449 (biological
process: ‘regulation of transcription’) or one of its des-
cendent terms. All proteins that do not have one of
these annotations in either the molecular function or the
biological process ontology of GO also are not considered
TcoFs. In summary, we only consider a protein to be a
TcoF if it satisﬁes all conditions shown in Table 1.
On the other hand, proteins that satisfy both conditions
1 and 2 but do not satisfy both conditions 3 and 4 are
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529 TcoFs were identiﬁed in this way. This leaves 1771
proteins to be characterized as ‘TF binding proteins’.
Since this way of characterizing TcoFs is heavily de-
pendent on protein annotations in GO, we subsequently
divided the TcoFs into different groups based on the type
of evidence that is given for each relevant annotation in
GO. For this purpose, we consider two groups of evidence
given in GO: experimental evidence consisting of the
evidence codes EXP, IDA, IMP, IGI, IEP and IPI and
non-experimental evidence consisting of all other evidence
codes (see http://www.geneontology.org/GO.evidence
.shtml for details on evidence in GO). We then divide
the TcoFs into the following four groups, based on the
type of evidence that is present for the fulﬁlment of con-
ditions 3 and 4 from Table 1:
. High-conﬁdence TcoFs: All TcoFs that have experi-
mental evidence for both, involvement in transcription
regulation and for occurrence in the cell nucleus.
. Hypothetical TcoFs (Class 1): All TcoFs that have
experimental evidence for involvement in transcription
regulation, but only non-experimental evidence (e.g.
‘Inferred from Electronic Annotation’ or ‘Author
statement’) for occurrence in the cell nucleus.
. Hypothetical TcoFs (Class 2): All TcoFs that have
experimental evidence for occurrence in the cell
nucleus, but only non-experimental evidence for in-
volvement in transcription regulation.
. Hypothetical TcoFs (Class 3): All TcoFs that have
only non-experimental evidence for both, involvement
in transcription regulation and for occurrence in the
cell nucleus.
This classiﬁcation leads to a distribution of TcoFs
among the four groups as can be seen in Table 2.
Only TcoFs that have experimental evidence cited for at
least one GO annotation relevant to the regulation of
transcription and have experimental evidence cited for oc-
currence in the cell nucleus are considered TcoFs with
high conﬁdence. If experimentally conﬁrmed evidence
for one of these is missing the protein is considered to
be a hypothetical TcoF. The level of conﬁdence for a
hypothetical TcoF decreases the higher the number of
the hypothetical TcoF class.
In a ﬁnal step, all data have been incorporated in a
relational database (PostgreSQL version 8.4) and a
simple web-interface has been implemented. The
database can be accessed through http://cbrc.kaust.edu
.sa/tcof/ or http://apps.sanbi.ac.za/tcof/. The interface
allows for the search of human proteins by their name
or Uniprot identiﬁers (Uniprot ID or accession number).
Alternative names for proteins, as given in the Uniprot
Knowledge Base (26), are included in the name search
wherever possible. The possibility of viewing predeﬁned
sets of proteins like TFs and TcoFs also exists. The
viewing of TcoFs can be narrowed by viewing only
TcoFs of certain groups. The results page will give a com-
prehensive overview of all interactions. For each TF it is
shown what other TFs it interacts with and what inter-
actions with TcoFs and other interacting proteins are
evident. For each TcoF and for each other protein inter-
acting with a TF, a list of TFs that it interacts with is
displayed. On each page outlining protein details the
evidence for a protein’s status is also displayed.
Online help and a user manual are also available
through the aforementioned URL. These will aid the
user in successfully exploiting this database resource. In
addition, we provide the core data of our database for
download in a format that can be easily processed by a
computer. The database will be updated annually.
DISCUSSION
To the best of our knowledge, this database constitutes the
only currently available resource that provides compre-
hensive information about PPIs of human TFs, human
TcoF and other human proteins that interact with
human TFs. While there are numerous resources regard-
ing PPI publicly available (44), none of them provides in-
formation speciﬁcally related to protein involvement in
transcriptional regulation, and neither do they provide
any mechanism to directly search for such information.
The TcoF-DB database is developed with the under-
standing that a TcoF is a protein that has a proven
binding interaction with a known TF, but does itself not
directly bind to the regulatory DNA region. A TcoF is
Table 2. Distribution of TcoFs among groups
TcoF groups Evidence for involvement in transcription regulation
Experimental (%) Non-experimental (%)
Evidence for location in cell nucleus Experimental 155 (29.3) High conﬁdence 96 (18.1) Hypothetical (Class2)
Non-experimental 62 (11.7) Hypothetical (Class 1) 216 (40.8) Hypothetical (Class 3)
Table 1. A proteins is only considered a TcoF if it satisﬁes these
four conditions
No. Condition
1 The protein is not characterized as a TF.
2 It is shown to bind to a known transcription factor. This
binding was demonstrated by experiment and is referenced
in scientiﬁc literature.
3 It is annotated in Gene Ontology with GO:0005634
(‘nucleus’).
4 It is annotated in Gene Ontology with GO:0030528
(‘transcription regulator activity’) or one of its descendent
terms or with GO:0045449 (‘regulation of transcription’)
or one of its descendent terms.
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tion of transcription. While it is true that the mechanism
of transcription regulation involves larger protein
complexes, we have concentrated our efforts on inter-
actions between two proteins one of which is a known
TF. The method by which we have chosen TFs provides
a high accuracy of the TF set. We rely on a previously
published set of TFs that was manually curated and we
added a small number of manually curated TFs to this set.
Thus, all TFs in our set have been hand-curated at some
stage during the process of establishing our set of known
TF.
Although, we have applied stringent requirements for a
protein to be considered a TcoF, we still rely on annota-
tions in GO for determining whether a protein is involved
in the regulation of transcription. We are aware that GO is
in some cases unreliable due to incomplete or erroneous
annotations, but we are not aware of an equally rich data
source for functional annotations for human proteins. In
order to enable users to judge the reliability of the anno-
tations of a given protein, we have included detailed in-
formation about the evidence cited for each annotation
used to classify a protein as a TcoF, including GO
evidence code, evidence type and a reference pointing to
the data source. Thus, it is possible for the user to quickly
distinguish between TcoFs whose classiﬁcation solely
depends on non-experimental evidence such as automatic
annotations or author statements from those whose anno-
tation has been experimentally conﬁrmed.
It must also be said that the reliability of the identiﬁca-
tion of TcoFs that we performed is also dependent on the
availability of PPI data in one of the resources we utilized.
Missing or erroneous data in these resources will inevit-
ably lead to the misclassiﬁcation of TcoFs in TcoF-DB.
However, we beneﬁt from using four resources in parallel
in the extraction of PPI data.
The average numbers of interactions per TF and TcoF
show that interactions happen abundantly in transcrip-
tional regulation. The fact that more than half of the
known human TFs have at least one proven PPI under-
lines the importance of PPI and TcoF for the understand-
ing of transcriptional regulation. The arithmetic mean for
the number of interactions per TFs is 1.8 for TF–TcoFs
interactions, 1.7 for TF–TF interactions and 2.7 for inter-
actions between TFs and other proteins. Because for each
of these interaction types more than half our TFs do not
have an interaction, the median values for these inter-
actions are all zero. This means that the average TF inter-
acts with 1.7 other TFs, 1.8 TcoFs and 2.7 other proteins.
At the same time more than half of the TFs do not have an
interaction with another protein of a given type.
Considering all protein types (TFs, TcoFs and other
proteins) 712 out of 1365 TFs have an interaction. The
difference between the arithmetic mean and the median
values described above also illustrates the fact that there
are a number of TFs which are very promiscuous regard-
ing PPI. The TF ‘cellular tumour antigen p53’ is one of the
best-studied human TFs (13). It is also one of the most
promiscuous TFs regarding reported PPI. For this TF, we
report 313 unique interacting proteins, 35 other TFs, 99
TcoFs (31 out of the high-conﬁdence group) and 179 other
proteins. The human TF ‘TATA-box binding protein’ is
also promiscuous, interacting with 71 TcoFs (17 out of the
high-conﬁdence group), 33 other TFs and 26 other
proteins. These TFs are two of the most interacting TFs
in our database. With 1365 TFs and 529 TcoFs (155
high-conﬁdence TcoFs, 374 hypothetical TcoFs)
indentiﬁed in this database, we can conﬁrm a previous
estimate that 10% of the human proteome is directly
involved in transcriptional regulation (45). With human
TFs having a total of 7045 interactions with other
human proteins, the number of TF–protein complexes
possibly involved in transcription is signiﬁcantly larger
than the number of TFs.
One has to keep in mind that our classiﬁcation of TcoFs
depends on annotation data which in turn depends on
experiments and data submissions. Such data is often in-
accurate and incomplete, frequently focusing only on a
speciﬁc cell location or speciﬁc function while alternative
cell locations in which the protein expresses and/or alter-
native protein functions remain elusive. For this reason,
proteins that have a proven interaction with a known TF,
but are not classiﬁed as a TcoF in our database, because
they lack the annotation to support such a claim, play an
important role. The reason for this is that in some cases
they might represent candidates for proteins with roles in
transcriptional regulation.
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